Cigna CEO granted options, 3,113 restricted shares
Cigna Group CEO Brian C. Evanko received new option and restricted stock awards, increasing his direct and indirect equity holdings.
Rhea-AI Filing Summary
Cigna Group (CI) reports that President and Chief Executive Officer Brian C. Evanko received equity awards on September 1, 2026. He was granted 6,716 stock options with an exercise price of $281.1325 per share and a separate award of 3,113 restricted shares, both vesting in three equal annual installments beginning September 1, 2027. Following these grants, he holds 41,030 common shares directly, plus indirect holdings of 25,614 shares through a GRAT and 919.5791 shares through Cigna’s 401(k) Plan. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 9,829 shares
Grant/Award
4 txns
Insider
Evanko Brian C
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) F3 | 6,716 | $0.00 | $0.00 |
| Grant/Award | Common Stock, $.01 Par Value F1 | 3,113 | $0.00 | $0.00 |
| holding | Common Stock, $.01 Par Value | -- | -- | -- |
| holding | Common Stock, $.01 Par Value F2 | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 6,716 contracts (Direct);
Common Stock, $.01 Par Value — 41,030 shares (Direct);
Common Stock, $.01 Par Value — 25,614 shares (Indirect, By GRAT);
Common Stock, $.01 Par Value — 919.5791 shares (Indirect, By 401(k))
Footnotes (3)
- F1. These restricted shares vest in three equal annual installments beginning September 1, 2027.
- F2. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
- F3. This option vests in three equal annual installments beginning September 1, 2027.
Key Figures
Stock options granted: 6,716 options
Option exercise price: $281.1325 per share
Restricted shares granted: 3,113 shares
+5 more
8 metrics
Stock options granted
6,716 options
Employee stock options granted to Brian C. Evanko on September 1, 2026
Option exercise price
$281.1325 per share
Exercise price for 6,716 employee stock options granted on September 1, 2026
Restricted shares granted
3,113 shares
Restricted common shares granted on September 1, 2026, vesting over three years
Direct common shares after transaction
41,030 shares
Direct Cigna Group common stock holdings of Brian C. Evanko after the grants
Indirect GRAT holdings
25,614 shares
Cigna Group common stock held indirectly by GRAT associated with Brian C. Evanko
Indirect 401(k) holdings
919.5791 shares
Cigna Group common stock held indirectly through The Cigna Group's 401(k) Plan
Option expiration date
September 1, 2037
Expiration date of the 6,716 employee stock options granted
Vesting commencement
September 1, 2027
Start date for three-year vesting of both restricted shares and options
Key Terms
Employee Stock Option, restricted shares, 401(k) Plan, GRAT
4 terms
Employee Stock Option financial
"Security titled "Employee Stock Option (Right to Buy)" was granted"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
401(k) Plan financial
"Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
GRAT financial
"Indirect ownership noted as "By GRAT" for certain holdings"
FAQ
What equity awards did Cigna Group (CI) grant to Brian C. Evanko on September 1, 2026?
On September 1, 2026, Brian C. Evanko was granted 6,716 stock options with a $281.1325 exercise price and 3,113 restricted shares of Cigna Group common stock, both vesting in three equal annual installments beginning September 1, 2027.
What indirect Cigna Group (CI) holdings are reported for Brian C. Evanko?
Indirectly, Brian C. Evanko is reported to hold 25,614 Cigna Group shares through a GRAT and 919.5791 shares through The Cigna Group’s 401(k) Plan, as of the September 1, 2026 Form 4.
What is the vesting schedule for Brian C. Evanko’s new Cigna (CI) stock options?
The 6,716 stock options granted to Brian C. Evanko vest in three equal annual installments beginning September 1, 2027, and are exercisable at $281.1325 per share until their expiration on September 1, 2037.
Were Brian C. Evanko’s Cigna (CI) transactions under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is marked to indicate no Rule 10b5-1 trading plan for these September 1, 2026 equity awards.
AI-generated analysis. How Rhea-AI works. Not financial advice.
